These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1312868

  • 21. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
    Ciardiello F, Tortora G, Bianco C, Selvam MP, Basolo F, Fontanini G, Pacifico F, Normanno N, Brandt R, Persico MG.
    Oncogene; 1994 Jan; 9(1):291-8. PubMed ID: 8302592
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides.
    Alahari SK, Dean NM, Fisher MH, Delong R, Manoharan M, Tivel KL, Juliano RL.
    Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825
    [Abstract] [Full Text] [Related]

  • 23. Nck inhibits NGF and basic FGF induced PC12 cell differentiation via mitogen-activated protein kinase-independent pathway.
    Rockow S, Tang J, Xiong W, Li W.
    Oncogene; 1996 Jun 06; 12(11):2351-9. PubMed ID: 8649775
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of differentiation in P19 embryonal carcinoma cells by the expression of vectors encoding truncated or antisense EGF receptor.
    Wu JX, Adamson ED.
    Dev Biol; 1993 Sep 04; 159(1):208-22. PubMed ID: 8365561
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G, Negroni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B.
    Cancer Res; 1992 Aug 01; 52(15):4221-6. PubMed ID: 1638535
    [Abstract] [Full Text] [Related]

  • 31. Antisense technology: biological utility and practical considerations.
    Neckers L, Whitesell L.
    Am J Physiol; 1993 Jul 01; 265(1 Pt 1):L1-12. PubMed ID: 8393300
    [Abstract] [Full Text] [Related]

  • 32. [Control of gene expression by antisense nucleic acids].
    Lebleu B, Clarenc JP, Degols G, Leonetti JP, Milhaud P.
    C R Seances Soc Biol Fil; 1992 Jul 01; 186(5):560-6. PubMed ID: 1305901
    [Abstract] [Full Text] [Related]

  • 33. Antisense oligonucleotides.
    Calabretta B, Skorski T, Zon G.
    Semin Cancer Biol; 1992 Dec 01; 3(6):391-8. PubMed ID: 1286160
    [Abstract] [Full Text] [Related]

  • 34. Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides.
    Neckers L, Rosolen A, Fahmy B, Whitesell L.
    Ann N Y Acad Sci; 1992 Oct 28; 660():37-44. PubMed ID: 1340154
    [No Abstract] [Full Text] [Related]

  • 35. [The application of antisense technology in ophthalmology].
    Guo Y, Ge J.
    Yan Ke Xue Bao; 1998 Jun 28; 14(2):108-15. PubMed ID: 12580046
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA.
    Stein D, Foster E, Huang SB, Weller D, Summerton J.
    Antisense Nucleic Acid Drug Dev; 1997 Jun 28; 7(3):151-7. PubMed ID: 9212905
    [Abstract] [Full Text] [Related]

  • 39. Antisense strategies for the control of aberrant gene expression.
    Sczakiel G.
    J Hematother; 1994 Jun 28; 3(4):305-13. PubMed ID: 7735826
    [Abstract] [Full Text] [Related]

  • 40. Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides.
    Hélène C.
    Eur J Cancer; 1991 Jun 28; 27(11):1466-71. PubMed ID: 1835863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.